At a glance
ClinicalIndex Comparison RecordN/ACompleted· 98 enrolled
Drug / intervention
Nicotine lozengedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
In Brief
A clinical study evaluating Nicotine lozenge for Tobacco Use Disorder. Completed, enrolled 98 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedFeb 2012
Primary CompletionJan 2014
TodayJul 2026
First PostedFeb 1, 2012
Enrollment StartDec 1, 2011
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.4 years ago
Interventions
Nicotine lozengedrug
A single dose of nicotine lozenge will be given at various timepoints relative to completion of a somewhat stressful task